Thomas Stephan
Stock Analyst at Stifel
(1.85)
# 3,080
Out of 4,876 analysts
44
Total ratings
37.93%
Success rate
-8.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $101.42 | +13.39% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $12.67 | +120.99% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $4.30 | -6.98% | 7 | Mar 6, 2025 | |
| STAA STAAR Surgical Company | Maintains: Buy | $38 → $20 | $16.92 | +18.20% | 9 | Feb 12, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $12.40 | +45.16% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $0.89 | +123.81% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $87.81 | +13.88% | 4 | May 15, 2024 |
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $101.42
Upside: +13.39%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $12.67
Upside: +120.99%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $4.30
Upside: -6.98%
STAAR Surgical Company
Feb 12, 2025
Maintains: Buy
Price Target: $38 → $20
Current: $16.92
Upside: +18.20%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $12.40
Upside: +45.16%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $0.89
Upside: +123.81%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $87.81
Upside: +13.88%